{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:52:58Z","timestamp":1791499978811,"version":"4.3.4"},"reference-count":186,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T00:00:00Z","timestamp":1699315200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.biopha.2023.115875","type":"journal-article","created":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T05:27:37Z","timestamp":1700112457000},"page":"115875","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Nano and microparticle drug delivery systems for the treatment of Brucella infections"],"prefix":"10.1016","volume":"169","author":[{"given":"Ali","family":"Razei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Javanbakht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Hajizade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Heiat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossien","family":"Aghamollaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojtaba","family":"Saadati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Khafaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mosa","family":"Asadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Cegolon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Homayoun","family":"Keihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biopha.2023.115875_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.21307\/pjm-2018-029","article-title":"Brucella - virulence factors, pathogenesis and treatment","volume":"67","author":"G\u0142owacka","year":"2018","journal-title":"Pol. J. Microbiol"},{"issue":"1","key":"10.1016\/j.biopha.2023.115875_bib2","first-page":"1500846","article-title":"Comparisons of brucellosis between human and veterinary medicine","volume":"8","author":"Hull","year":"2018","journal-title":"Infect. Ecol. Epidemiol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115875_bib3","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3390\/pathogens10020186","article-title":"Brucella: reservoirs and niches in animals and humans","volume":"10","author":"Gonz\u00e1lez-Espinoza","year":"2021","journal-title":"Pathogens"},{"issue":"20","key":"10.1016\/j.biopha.2023.115875_bib4","doi-asserted-by":"crossref","first-page":"7749","DOI":"10.3390\/ijms21207749","article-title":"Brucella genomics: macro and micro evolution","volume":"21","author":"Su\u00e1rez-Esquivel","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2023.115875_bib5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.20506\/rst.32.1.2188","article-title":"Epidemiology of brucellosis in domestic animals caused by Brucella melitensis, Brucella suis and Brucella abortus","volume":"32","author":"D\u00edaz Aparicio","year":"2013","journal-title":"Rev. Sci. Tech."},{"issue":"6","key":"10.1016\/j.biopha.2023.115875_bib6","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.micinf.2008.01.005","article-title":"Evidence of Brucella abortus OPS dictating uptake and restricting NF-kappaB activation in murine macrophages.","volume":"10","author":"Pei","year":"2008","journal-title":"Microbes Infect."},{"issue":"3","key":"10.1016\/j.biopha.2023.115875_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00380-19","article-title":"A Role for the VPS retromer in Brucella intracellular replication revealed by genomewide siRNA screening","volume":"4","author":"Casanova","year":"2019","journal-title":"mSphere"},{"issue":"3","key":"10.1016\/j.biopha.2023.115875_bib8","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1128\/IAI.71.3.1481-1490.2003","article-title":"Role of the Brucella suis lipopolysaccharide O antigen in phagosomal genesis and in inhibition of phagosome-lysosome fusion in murine macrophages","volume":"71","author":"Porte","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biopha.2023.115875_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.713157","article-title":"When the going gets rough: the significance of Brucella lipopolysaccharide phenotype in host-pathogen interactions","volume":"12","author":"Stranahan","year":"2021","journal-title":"Front Microbiol"},{"issue":"3","key":"10.1016\/j.biopha.2023.115875_bib10","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1574-6976.2012.00334.x","article-title":"Internal affairs: investigating the Brucella intracellular lifestyle","volume":"36","author":"von Bargen","year":"2012","journal-title":"FEMS Microbiol Rev."},{"issue":"3","key":"10.1016\/j.biopha.2023.115875_bib11","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.micinf.2009.12.008","article-title":"Cholesterol, ganglioside GM1 and class A scavenger receptor contribute to infection by Brucella ovis and Brucella canis in murine macrophages","volume":"12","author":"Mart\u00edn-Mart\u00edn","year":"2010","journal-title":"Microbes Infect."},{"issue":"4","key":"10.1016\/j.biopha.2023.115875_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010216","article-title":"Transcriptome analysis of the Brucella abortus BvrR\/BvrS two-component regulatory system","volume":"5","author":"Viadas","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2023.115875_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.micpath.2004.04.002","article-title":"Lipid raft microdomains mediate class A scavenger receptor-dependent infection of Brucella abortus","volume":"37","author":"Kim","year":"2004","journal-title":"Micro Pathog."},{"key":"10.1016\/j.biopha.2023.115875_bib14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fcimb.2012.00055","article-title":"Host interferon-\u03b3 inducible protein contributes to Brucella survival","volume":"2","author":"Ritchie","year":"2012","journal-title":"Front Cell Infect. Microbiol"},{"issue":"12","key":"10.1016\/j.biopha.2023.115875_bib15","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1111\/j.1462-5822.2006.00754.x","article-title":"Characterization of SP41, a surface protein of Brucella associated with adherence and invasion of host epithelial cells","volume":"8","author":"Casta\u00f1eda-Rold\u00e1n","year":"2006","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.biopha.2023.115875_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2017.02217","article-title":"Modulation of microtubule dynamics affects Brucella abortus intracellular survival, pathogen-containing vacuole maturation, and pro-inflammatory cytokine production in infected macrophages","volume":"8","author":"Alves-Silva","year":"2017","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.biopha.2023.115875_bib17","doi-asserted-by":"crossref","DOI":"10.1186\/s12860-019-0239-7","article-title":"Binding of Brucella protein, Bp26, to select extracellular matrix molecules","volume":"20","author":"ElTahir","year":"2019","journal-title":"BMC Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115875_bib18","doi-asserted-by":"crossref","DOI":"10.1007\/s00203-021-02664-1","article-title":"Brucella melitensis invA gene (BME_RS01060) transcription is promoted under acidic stress conditions","volume":"204","author":"Sauceda-Becerra","year":"2021","journal-title":"Arch. Microbiol"},{"issue":"5","key":"10.1016\/j.biopha.2023.115875_bib19","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1600-0854.2008.00718.x","article-title":"Brucella intracellular replication requires trafficking through the late endosomal\/lysosomal compartment","volume":"9","author":"Starr","year":"2008","journal-title":"Traffic"},{"issue":"24","key":"10.1016\/j.biopha.2023.115875_bib20","doi-asserted-by":"crossref","first-page":"13637","DOI":"10.3390\/ijms222413637","article-title":"The VirB system plays a crucial role in Brucella intracellular infection","volume":"22","author":"Xiong","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2023.115875_bib21","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/lam.12231","article-title":"The Brucella suis IbpA heat-shock chaperone is not required for virulence or for expression of the VirB type IV secretion system VirB8 protein","volume":"58","author":"Berta","year":"2014","journal-title":"Lett. Appl. Microbiol"},{"issue":"1","key":"10.1016\/j.biopha.2023.115875_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/MMBR.00021-19","article-title":"Uncovering the hidden credentials of Brucella virulence","volume":"85","author":"Roop","year":"2021","journal-title":"Microbiol Mol. Biol. Rev."},{"issue":"5","key":"10.1016\/j.biopha.2023.115875_bib23","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3390\/biom10050788","article-title":"Different impacts of MucR binding to the babR and virB Promoters on gene expression in Brucella abortus 2308","volume":"10","author":"Borriello","year":"2020","journal-title":"Biomolecules"},{"issue":"7","key":"10.1016\/j.biopha.2023.115875_bib24","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.3390\/ijms22073673","article-title":"The mechanism of facultative intracellular parasitism of Brucella","volume":"22","author":"Jiao","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.115875_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fcimb.2016.00153","article-title":"A T4SS effector targets host cell alpha-enolase contributing to Brucella abortus intracellular lifestyle","volume":"6","author":"Marchesini","year":"2016","journal-title":"Front Cell Infect. Microbiol"},{"issue":"11","key":"10.1016\/j.biopha.2023.115875_bib26","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3390\/pathogens9110942","article-title":"Adhesins of Brucella: their roles in the interaction with the host","volume":"9","author":"Bialer","year":"2020","journal-title":"Pathogens"},{"issue":"10","key":"10.1016\/j.biopha.2023.115875_bib27","first-page":"CD007179","article-title":"Antibiotics for treating human brucellosis","volume":"10","author":"Yousefi-Nooraie","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.biopha.2023.115875_bib28","doi-asserted-by":"crossref","unstructured":"Alavi S.M., Motlagh M.E. A Review of Epidemiology, Diagnosis and Management of Brucellosis for General Physicians Working in the Iranian Health Network. Jundishapour J Microbiol. 5(2):384\u2013387.","DOI":"10.5812\/jjm.3248"},{"issue":"7","key":"10.1016\/j.biopha.2023.115875_bib29","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00004-21","article-title":"Intracellular passage triggers a molecular response in brucella abortus that increases its infectiousness","volume":"89","author":"Altamirano-Silva","year":"2021","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biopha.2023.115875_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpc.2023.106958","article-title":"Interaction of gentamicin and gentamicin-AOT with poly-(lactide-co-glycolate) in a drug delivery system - density functional theory calculations and molecular dynamics simulation","volume":"294","author":"Duran","year":"2023","journal-title":"Biophys. Chem."},{"issue":"7","key":"10.1016\/j.biopha.2023.115875_bib31","first-page":"15492","article-title":"Nanotechnology and nanomedicine: start small, think big","volume":"5","author":"Kargozar","year":"2018","journal-title":"Mater. Today.: Proc."},{"issue":"1","key":"10.1016\/j.biopha.2023.115875_bib32","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.nano.2006.11.008","article-title":"The present and future of nanotechnology in human health care","volume":"3","author":"Sahoo","year":"2007","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.biopha.2023.115875_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2006.10.021","article-title":"Nanoparticles--a historical perspective","volume":"331","author":"Kreuter","year":"2007","journal-title":"Int J. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2023.115875_bib34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.12989\/anr.2017.5.1.049","article-title":"An overview on recent new nano-anti-parasitological findings and application","volume":"5","author":"Farhoudi","year":"2017","journal-title":"Advan Nano Res."},{"issue":"4","key":"10.1016\/j.biopha.2023.115875_bib35","doi-asserted-by":"crossref","first-page":"142P","DOI":"10.1042\/bj1280142Pb","article-title":"Lysosomal localization of enzyme-containing liposomes injected into rats","volume":"128","author":"Gregoriadis","year":"1972","journal-title":"Biochem J."},{"issue":"7","key":"10.1016\/j.biopha.2023.115875_bib36","first-page":"498","article-title":"Albumin microspheres for study of the reticuloendothelial system","volume":"13","author":"Scheffel","year":"1972","journal-title":"J. Nucl. Med."},{"issue":"1","key":"10.1016\/j.biopha.2023.115875_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/03639048109055684","article-title":"Development of biodegradable and injectable latices for controlled release of potent drugs","volume":"7","author":"Gurny","year":"1981","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2023.115875_bib38","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.biopha.2023.115875_bib39","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.2147\/DDDT.S142337","article-title":"The new era of nanotechnology, an alternative to change cancer treatment","volume":"11","author":"Jurj","year":"2017","journal-title":"Drug Des. Devel Ther."},{"issue":"1","key":"10.1016\/j.biopha.2023.115875_bib40","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-022-01605-4","article-title":"Engineering nano-drug biointerface to overcome biological barriers toward precision drug delivery","volume":"20","author":"Waheed","year":"2022","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.biopha.2023.115875_bib41","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6231482","article-title":"Nanoparticles in medicine: a focus on vascular oxidative stress","volume":"2018","author":"Mauricio","year":"2018","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.biopha.2023.115875_bib42","article-title":"Nanotherapeutics in cancer prevention, diagnosis and treatment","author":"Krishnan","year":"2014","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2023.115875_bib43","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.drudis.2018.08.010","article-title":"Advancing precision medicine with personalized drug screening","volume":"24","author":"Gorshkov","year":"2019","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.biopha.2023.115875_bib44","doi-asserted-by":"crossref","DOI":"10.1186\/s12941-019-0333-x","article-title":"Doxycycline-encapsulated solid lipid nanoparticles for the enhanced antibacterial potential to treat the chronic brucellosis and preventing its relapse: in vivo study","volume":"18","author":"Hosseini","year":"2019","journal-title":"Ann. Clin. Microbiol Antimicrob."},{"issue":"16","key":"10.1016\/j.biopha.2023.115875_bib45","doi-asserted-by":"crossref","first-page":"19073","DOI":"10.1007\/s11356-018-3913-y","article-title":"Advanced applications of nanotechnology in veterinary medicine","volume":"27","author":"El-Sayed","year":"2020","journal-title":"Environ. Sci. Pollut. Res. Int."},{"issue":"1","key":"10.1016\/j.biopha.2023.115875_bib46","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1574-6968.2009.01530.x","article-title":"Targeting Brucella melitensis with polymeric nanoparticles containing streptomycin and doxycycline","volume":"294","author":"Seleem","year":"2009","journal-title":"FEMS Microbiol Lett."},{"issue":"6","key":"10.1016\/j.biopha.2023.115875_bib47","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ijantimicag.2004.07.010","article-title":"Chemotherapeutic efficacy of poly (DL-lactide-co-glycolide) nanoparticle encapsulated antitubercular drugs at sub-therapeutic dose against experimental tuberculosis","volume":"24","author":"Sharma","year":"2004","journal-title":"Int J. Antimicrob. Agents"},{"issue":"3","key":"10.1016\/j.biopha.2023.115875_bib48","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jconrel.2004.12.012","article-title":"Etanidazole in pH-sensitive liposomes: design, characterization and in vitro\/in vivo anti-Trypanosoma cruzi activity","volume":"103","author":"Morilla","year":"2005","journal-title":"J. Control Release"},{"issue":"7","key":"10.1016\/j.biopha.2023.115875_bib49","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3390\/molecules21070867","article-title":"Advanced nanobiomaterials: vaccines, diagnosis and treatment of infectious diseases","volume":"21","author":"Torres-Sangiao","year":"2016","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.biopha.2023.115875_bib50","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1021\/cr068445e","article-title":"Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications","volume":"108","author":"Laurent","year":"2008","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biopha.2023.115875_bib51","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.7595.1","article-title":"Nanoparticle-based antimicrobials: surface functionality is critical","volume":"5","author":"Gupta","year":"2016","journal-title":"F1000Res"},{"issue":"7","key":"10.1016\/j.biopha.2023.115875_bib52","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3390\/antibiotics11070951","article-title":"Overcoming methicillin-resistance Staphylococcus aureus (MRSA) using antimicrobial peptides-silver nanoparticles","volume":"11","author":"Masimen","year":"2022","journal-title":"Antibiotics"},{"issue":"6","key":"10.1016\/j.biopha.2023.115875_bib53","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1590\/0037-8682-0139-2014","article-title":"Emergence of antibiotic-resistant bacterial strains, methicillin-resistant Staphylococcus aureus, extended spectrum beta lactamases, and multi-drug resistance is a problem similar to global warming","volume":"47","author":"Bhattacharya","year":"2014","journal-title":"Rev. Soc. Bras. Med Trop."},{"issue":"1","key":"10.1016\/j.biopha.2023.115875_bib54","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-020-01807-3","article-title":"Antimicrobial activity of mesenchymal stem cells against Staphylococcus aureus","volume":"11","author":"Yagi","year":"2020","journal-title":"Stem Cell Res. Ther."},{"issue":"12","key":"10.1016\/j.biopha.2023.115875_bib55","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1002\/stem.544","article-title":"Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37","volume":"28","author":"Krasnodembskaya","year":"2010","journal-title":"Stem Cells"},{"key":"10.1016\/j.biopha.2023.115875_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/srep24312","article-title":"In vitro antibacterial activity of ZnO and Nd doped ZnO nanoparticles against ESBL producing Escherichia coli and Klebsiella pneumoniae","volume":"6","author":"Hameed","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2023.115875_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-06657-y","article-title":"Antibacterial action and target mechanisms of zinc oxide nanoparticles against bacterial pathogens","volume":"12","author":"Mendes","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.115875_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.fochx.2023.100684","article-title":"Recent insights into nanoemulsions: their preparation, properties and applications","volume":"18","author":"Mushtaq","year":"2023","journal-title":"Food Chem. X"},{"key":"10.1016\/j.biopha.2023.115875_bib59","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.addr.2019.01.013","article-title":"Nanotechnology in cell replacement therapies for type 1 diabetes","volume":"139","author":"Ernst","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.biopha.2023.115875_bib60","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.3390\/ijms23084339","article-title":"Interactions between nanoparticles and intestine","volume":"23","author":"Vitulo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.biopha.2023.115875_bib61","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1039\/D0BM02164D","article-title":"A comprehensive review on the applications of nano-biosensor-based approaches for non-communicable and communicable disease detection","volume":"9","author":"George Kerry","year":"2021","journal-title":"Biomater. Sci."},{"issue":"11\u201312","key":"10.1016\/j.biopha.2023.115875_bib62","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0956-5663(02)00089-1","article-title":"Bio-smart hydrogels: co-joined molecular recognition and signal transduction in biosensor fabrication and drug delivery","volume":"17","author":"Brahim","year":"2002","journal-title":"Biosens. Bioelectron."},{"issue":"6","key":"10.1016\/j.biopha.2023.115875_bib63","article-title":"Superoxide dismutase-loaded nanoparticles attenuate myocardial ischemia-reperfusion injury and protect against chronic adverse ventricular remodeling","volume":"4","author":"Altshuler","year":"2021","journal-title":"Adv. Ther."},{"issue":"7","key":"10.1016\/j.biopha.2023.115875_bib64","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/term.1703","article-title":"The potential of tissue engineering for developing alternatives to animal experiments: a systematic review","volume":"9","author":"de Vries","year":"2015","journal-title":"J. Tissue Eng. Regen. Med."},{"issue":"1","key":"10.1016\/j.biopha.2023.115875_bib65","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-022-01450-5","article-title":"Advances of nano drug delivery system for the theranostics of ischemic stroke","volume":"20","author":"Lv","year":"2022","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.biopha.2023.115875_bib66","doi-asserted-by":"crossref","first-page":"6757","DOI":"10.2147\/IJN.S93918","article-title":"Recent trends in the development of nanophytobioactive compounds and delivery systems for their possible role in reducing oxidative stress in Parkinson's disease models","volume":"10","author":"Ganesan","year":"2015","journal-title":"Int J. Nanomed."},{"issue":"17","key":"10.1016\/j.biopha.2023.115875_bib67","doi-asserted-by":"crossref","first-page":"9118","DOI":"10.3390\/ijms22179118","article-title":"Targeted delivery of drugs and genes using polymer nanocarriers for cancer therapy","volume":"22","author":"Xia","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2023.115875_bib68","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1080\/10717544.2018.1477857","article-title":"Nanoparticle drug delivery systems: an excellent carrier for tumor peptide vaccines","volume":"25","author":"Wang","year":"2018","journal-title":"Drug Deliv."},{"issue":"10","key":"10.1016\/j.biopha.2023.115875_bib69","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1007\/s11095-014-1419-y","article-title":"Biomaterials for nanoparticle vaccine delivery systems","volume":"31","author":"Sahdev","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2023.115875_bib70","first-page":"156","article-title":"Application of nanoparticles drug delivery systems in the treatment of intracellular bacterial infections","volume":"29","author":"Razei","year":"2017","journal-title":"Minerva Biotec"},{"issue":"1","key":"10.1016\/j.biopha.2023.115875_bib71","doi-asserted-by":"crossref","DOI":"10.1186\/1745-6673-2-16","article-title":"Nanotechnology-based drug delivery systems","volume":"2","author":"Suri","year":"2007","journal-title":"J. Occup. Med Toxicol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115875_bib72","article-title":"Green synthesis of silver nanoparticles (AgNPs), structural characterization, and their antibacterial potential","volume":"20","author":"Asif","year":"2022","journal-title":"Dose Response"},{"issue":"4","key":"10.1016\/j.biopha.2023.115875_bib73","doi-asserted-by":"crossref","DOI":"10.1007\/s11274-019-2637-6","article-title":"Sensitizing of \u03b2-lactam resistance by tannic acid in methicillin-resistant S. aureus","volume":"35","author":"K\u0131rmusao\u011flu","year":"2019","journal-title":"World J. Microbiol Biotechnol."},{"key":"10.1016\/j.biopha.2023.115875_bib74","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.2147\/IJN.S196472","article-title":"Shape-dependent antimicrobial activities of silver nanoparticles","volume":"14","author":"Cheon","year":"2019","journal-title":"Int J. Nanomed."},{"key":"10.1016\/j.biopha.2023.115875_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics10121473","article-title":"Nanotechnology as a novel approach in combating microbes providing an alternative to antibiotics","author":"Mubeen","year":"2021","journal-title":"Antibiotics"},{"issue":"4","key":"10.1016\/j.biopha.2023.115875_bib76","doi-asserted-by":"crossref","first-page":"481","DOI":"10.4274\/tjps.galenos.2019.48751","article-title":"Nanocarriers used most in drug delivery and drug release: nanohydrogel, chitosan, graphene, and solid lipid","volume":"16","author":"\u00d6zkan","year":"2019","journal-title":"Turk. J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2023.115875_bib77","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3390\/molecules27030674","article-title":"Recent developments in nitric oxide donors and delivery for antimicrobial and anti-biofilm applications","volume":"27","author":"Poh","year":"2022","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.biopha.2023.115875_bib78","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1039\/C5TB01527H","article-title":"Nanotechnology solutions to restore antibiotic activity","volume":"4","author":"Shimanovich","year":"2016","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.biopha.2023.115875_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2022.100104","article-title":"Metal nanoparticles-assisted early diagnosis of diseases","volume":"8","author":"Jouyandeh","year":"2022","journal-title":"OpenNano"},{"key":"10.1016\/j.biopha.2023.115875_bib80","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-3-030-88071-2_2","article-title":"Trends in the design and evaluation of polymeric nanocarriers: the in vitro nano-bio interactions","volume":"1357","author":"Bettencourt","year":"2022","journal-title":"Adv. Exp. Med Biol."},{"key":"10.1016\/j.biopha.2023.115875_bib81","doi-asserted-by":"crossref","first-page":"7291","DOI":"10.2147\/IJN.S146315","article-title":"Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors","volume":"12","author":"Din","year":"2017","journal-title":"Int J. Nanomed."},{"key":"10.1016\/j.biopha.2023.115875_bib82","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.nantod.2018.12.006","article-title":"Gold nanoparticles in biological optical imaging","volume":"24","author":"Wu","year":"2019","journal-title":"Nano Today"},{"key":"10.1016\/j.biopha.2023.115875_bib83","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.cis.2017.05.003","article-title":"Iron oxide nanoparticles - In vivo\/in vitro biomedical applications and in silico studies","volume":"249","author":"Nedyalkova","year":"2017","journal-title":"Adv. Colloid Interface Sci."},{"issue":"4","key":"10.1016\/j.biopha.2023.115875_bib84","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s40139-021-00227-z","article-title":"Toxicology of nanoparticles in drug delivery","volume":"9","author":"Sharma","year":"2021","journal-title":"Curr. Pathobiol. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2023.115875_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2013007914","article-title":"Tiny technology proves big: a challenge at engineering, medicine and pharmaceutical sciences interface","volume":"31","author":"Mahapatra","year":"2014","journal-title":"Crit. Rev. Ther. Drug Carr. Syst."},{"issue":"4","key":"10.1016\/j.biopha.2023.115875_bib86","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.3390\/molecules27041372","article-title":"A review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives","volume":"27","author":"Liu","year":"2022","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.biopha.2023.115875_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09394","article-title":"Liposomes: structure, composition, types, and clinical applications","volume":"8","author":"Nsairat","year":"2022","journal-title":"Heliyon"},{"issue":"7","key":"10.1016\/j.biopha.2023.115875_bib88","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.3390\/molecules26072047","article-title":"Liposomes as antibiotic delivery systems: a promising nanotechnological strategy against antimicrobial resistance","volume":"26","author":"Ferreira","year":"2021","journal-title":"Molecules"},{"issue":"48","key":"10.1016\/j.biopha.2023.115875_bib89","doi-asserted-by":"crossref","DOI":"10.1039\/c3tb21238f","article-title":"Liposome-like nanostructures for drug delivery","volume":"1","author":"Gao","year":"2013","journal-title":"J. Mater. Chem. B"},{"issue":"5","key":"10.1016\/j.biopha.2023.115875_bib90","article-title":"Stimuli-responsive liposomes for drug delivery","volume":"9","author":"Lee","year":"2017","journal-title":"Wiley Inter. Rev. Nanomed. Nanobiotechnol"},{"key":"10.1016\/j.biopha.2023.115875_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2015.00286","article-title":"Advances and challenges of liposome assisted drug delivery","volume":"6","author":"Sercombe","year":"2015","journal-title":"Front Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2023.115875_bib92","doi-asserted-by":"crossref","first-page":"400","DOI":"10.2174\/1567201816666190201144815","article-title":"Nanomedicines as drug delivery carriers of anti-tubercular drugs: from pathogenesis to infection control","volume":"16","author":"Hussain","year":"2019","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.biopha.2023.115875_bib93","series-title":"Antibacterial Drug Discovery to Combat MDR","first-page":"441","article-title":"Targeted Delivery of Antibiotics Using Microparticles to Combat Multidrug-Resistant Tuberculosis","author":"Upadhyay","year":"2019"},{"issue":"5","key":"10.1016\/j.biopha.2023.115875_bib94","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s40265-019-01095-z","article-title":"Amikacin liposome inhalation suspension: a review in mycobacterium avium complex lung disease","volume":"79","author":"Shirley","year":"2019","journal-title":"Drugs"},{"issue":"12","key":"10.1016\/j.biopha.2023.115875_bib95","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.tips.2019.10.005","article-title":"Pharmacological and molecular mechanisms behind the sterilizing activity of pyrazinamide","volume":"40","author":"Gopal","year":"2019","journal-title":"Trends Pharm. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2023.115875_bib96","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jbiotec.2013.01.029","article-title":"Mutants of listeriolysin O for enhanced liposomal delivery of macromolecules","volume":"164","author":"Walls","year":"2013","journal-title":"J. Biotechnol."},{"issue":"3","key":"10.1016\/j.biopha.2023.115875_bib97","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijfoodmicro.2012.04.004","article-title":"Effect of liposome-encapsulated nisin and bacteriocin-like substance P34 on Listeria monocytogenes growth in Minas frescal cheese","volume":"156","author":"Malheiros Pda","year":"2012","journal-title":"Int J. Food Microbiol"},{"issue":"2","key":"10.1016\/j.biopha.2023.115875_bib98","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1039\/C5RA22098J","article-title":"Liposome containing nutmeg oil as the targeted preservative against Listeria monocytogenes in dumplings","volume":"6","author":"Lin","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.biopha.2023.115875_bib99","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijfoodmicro.2017.04.003","article-title":"Antimicrobial activity of free and liposome-encapsulated thymol and carvacrol against Salmonella and Staphylococcus aureus adhered to stainless steel","volume":"252","author":"Engel","year":"2017","journal-title":"Int. J. Food Microbiol"},{"issue":"17","key":"10.1016\/j.biopha.2023.115875_bib100","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201900564","article-title":"Bioinspired liposomes for oral delivery of colistin to combat intracellular infections by salmonella enterica","volume":"8","author":"Menina","year":"2019","journal-title":"Adv. Health Mater."},{"issue":"6","key":"10.1016\/j.biopha.2023.115875_bib101","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1128\/AAC.02555-13","article-title":"Liposome encapsulation of ciprofloxacin improves protection against highly virulent Francisella tularensis strain Schu S4","volume":"58","author":"Hamblin","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2023.115875_bib102","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejpb.2021.04.021","article-title":"Exploring the possible targeting strategies of liposomes against methicillin-resistant Staphylococcus aureus (MRSA)","volume":"165","author":"Mat Rani","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2023.115875_bib103","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0165-2427(85)90120-5","article-title":"Enhanced intraphagocytic killing of Brucella abortus in bovine mononuclear cells by liposomes-containing gentamicin","volume":"8","author":"Dees","year":"1985","journal-title":"Vet. Immunol. Immunopathol."},{"issue":"9","key":"10.1016\/j.biopha.2023.115875_bib104","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.2460\/ajvr.1989.50.09.1486","article-title":"Treatment of Brucella melitensis infection in mice by use of liposome-encapsulated gentamicin","volume":"50","author":"Hern\u00e1ndez-Caselles","year":"1989","journal-title":"Am. J. Vet. Res"},{"issue":"1","key":"10.1016\/j.biopha.2023.115875_bib105","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1128\/AAC.40.1.146","article-title":"Effect of composition and method of preparation of liposomes on their stability and interaction with murine monocytes infected with Brucella abortus","volume":"40","author":"Vitas","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.biopha.2023.115875_bib106","first-page":"204","article-title":"Protective effect of liposomal gentamicin against systemic acute murine brucellosis","volume":"43","author":"Vitas","year":"1997","journal-title":"Chemotherapy"},{"issue":"4","key":"10.1016\/j.biopha.2023.115875_bib107","doi-asserted-by":"crossref","first-page":"275","DOI":"10.29252\/ibj.22.4.275","article-title":"Preparation and evaluation of rifampicin and Co-trimoxazole-loaded nanocarrier against Brucella melitensis Infection","volume":"22","author":"Bodaghabadi","year":"2018","journal-title":"Iran. Biomed. J."},{"key":"10.1016\/j.biopha.2023.115875_bib108","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jconrel.2018.12.024","article-title":"Nanotherapeutic provides dose sparing and improved antimicrobial activity against Brucella melitensis infections","volume":"294","author":"Lueth","year":"2019","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2023.115875_bib109","article-title":"Gentamicin-loaded Chitosan nanoparticles improve its therapeutic effects on Brucella-infected J774A.1 murine cells","volume":"8","author":"Razei","year":"2019","journal-title":"Galen. Med J."},{"issue":"8","key":"10.1016\/j.biopha.2023.115875_bib110","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-020-01833-7","article-title":"Treatment of Brucellosis in guinea pigs via a combination of engineered novel ph-responsive curcumin niosome hydrogel and doxycycline-loaded chitosan-sodium alginate nanoparticles: an in vitro and in vivo study","volume":"21","author":"Abo El-Ela","year":"2020","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.biopha.2023.115875_bib111","article-title":"Solid lipid nanoparticles for drug delivery: pharmacological and biopharmaceutical aspects","volume":"7","author":"Scioli Montolo","year":"2020","journal-title":"Front Mol. Biosci."},{"issue":"6","key":"10.1016\/j.biopha.2023.115875_bib112","doi-asserted-by":"crossref","first-page":"669","DOI":"10.4155\/tde.15.23","article-title":"The use of solid lipid nanoparticles for sustained drug release","volume":"6","author":"Attama","year":"2015","journal-title":"Ther. Deliv."},{"issue":"4","key":"10.1016\/j.biopha.2023.115875_bib113","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.biopha.2023.115875_bib114","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1128\/AAC.00809-06","article-title":"Poly(D,L-lactide-coglycolide) particles containing gentamicin: pharmacokinetics and pharmacodynamics in Brucella melitensis-infected mice","volume":"51","author":"Lecaroz","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9\u201310","key":"10.1016\/j.biopha.2023.115875_bib115","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1166\/jnn.2006.478","article-title":"Nanocarriers with gentamicin to treat intracellular pathogens","volume":"6","author":"Lecaroz","year":"2006","journal-title":"J. Nanosci. Nanotechnol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115875_bib116","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.actbio.2010.11.031","article-title":"Novel bioactive hydrophobic gentamicin carriers for the treatment of intracellular bacterial infections","volume":"7","author":"Imbuluzqueta","year":"2011","journal-title":"Acta Biomater."},{"issue":"7","key":"10.1016\/j.biopha.2023.115875_bib117","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1128\/AAC.00378-13","article-title":"Hydrophobic gentamicin-loaded nanoparticles are effective against Brucella melitensis infection in mice","volume":"57","author":"Imbuluzqueta","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.biopha.2023.115875_bib118","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/21691401.2019.1593858","article-title":"Improved antibacterial function of Rifampicin-loaded solid lipid nanoparticles on Brucella abortus","volume":"47","author":"Ghaderkhani","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"6","key":"10.1016\/j.biopha.2023.115875_bib119","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/jac\/dkh227","article-title":"Gentamicin-loaded microspheres for reducing the intracellular Brucella abortus load in infected monocytes","volume":"53","author":"Prior","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"issue":"11","key":"10.1016\/j.biopha.2023.115875_bib120","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.3390\/nano12111855","article-title":"Recent advances in antimicrobial nano-drug delivery systems","volume":"12","author":"Zong","year":"2022","journal-title":"Nanomaterials"},{"issue":"20","key":"10.1016\/j.biopha.2023.115875_bib121","doi-asserted-by":"crossref","first-page":"13735","DOI":"10.1039\/D3RA01421E","article-title":"Organic and inorganic nanomaterials: fabrication, properties and applications","volume":"13","author":"Alshammari","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.biopha.2023.115875_bib122","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3389\/fmicb.2010.00134","article-title":"A brief history of the antibiotic era: lessons learned and challenges for the future","volume":"1","author":"Aminov","year":"2010","journal-title":"Front Microbiol"},{"key":"10.1016\/j.biopha.2023.115875_bib123","doi-asserted-by":"crossref","unstructured":"Chopra I., Hesse L., O'Neill A. Discovery and development of new anti-bacterial drugs, in Pharmacochemistry Library, vol 32, Trends in Drug Research III, ed. van der Goot H. (Amsterdam: Elsevier;), 2002;32:213\u2013225.","DOI":"10.1016\/S0165-7208(02)80022-8"},{"key":"10.1016\/j.biopha.2023.115875_bib124","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.2147\/IJN.S378074","article-title":"Nanotechnology: a promising approach for cancer diagnosis, therapeutics and theragnosis","volume":"17","author":"Dessale","year":"2022","journal-title":"Int J. Nanomed."},{"issue":"4","key":"10.1016\/j.biopha.2023.115875_bib125","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41565-021-00866-8","article-title":"Nanotechnology approaches for global infectious diseases","volume":"16","author":"Kirtane","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115875_bib126","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3390\/pharmaceutics14040883","article-title":"Nanocarrier drug delivery systems: characterization, limitations, future perspectives and implementation of artificial intelligence","volume":"14","author":"Alshawwa","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2023.115875_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112609","article-title":"Nano drug delivery in intracellular bacterial infection treatments","volume":"146","author":"Hosseini","year":"2022","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2023.115875_bib128","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fimmu.2018.00193","article-title":"Reinforcing the functionality of mononuclear phagocyte system to control tuberculosis","volume":"9","author":"Pahari","year":"2018","journal-title":"Front Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115875_bib129","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0955-0674(03)00083-8","article-title":"Phagocytosis: latex leads the way","volume":"15","author":"Desjardins","year":"2003","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.biopha.2023.115875_bib130","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.00065","article-title":"Mycobacterium tuberculosis dissemination plays a critical role in pathogenesis","volume":"10","author":"Moule","year":"2020","journal-title":"Front Cell Infect. Microbiol"},{"key":"10.1016\/j.biopha.2023.115875_bib131","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.620339","article-title":"The role of macrophages in Staphylococcus aureus Infection","volume":"11","author":"Pidwill","year":"2021","journal-title":"Front Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115875_bib132","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.tcb.2005.03.009","article-title":"The Trojan horse: survival tactics of pathogenic mycobacteria in macrophages","volume":"15","author":"Nguyen","year":"2005","journal-title":"Trends Cell Biol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115875_bib133","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.3390\/biomedicines10051203","article-title":"Current development of nano-drug delivery to target macrophages","volume":"10","author":"Cai","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.biopha.2023.115875_bib134","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s40199-020-00337-w","article-title":"Multi-functionalized nanocarriers targeting bacterial reservoirs to overcome challenges of multi drug-resistance","volume":"28","author":"Kiani","year":"2020","journal-title":"Daru"},{"issue":"2","key":"10.1016\/j.biopha.2023.115875_bib135","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/10611860903115290","article-title":"In vitro evaluation of surface functionalized gelatin nanoparticles for macrophage targeting in the therapy of visceral leishmaniasis","volume":"18","author":"Nahar","year":"2010","journal-title":"J. Drug Target"},{"issue":"5","key":"10.1016\/j.biopha.2023.115875_bib136","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.biomaterials.2006.09.047","article-title":"Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery","volume":"28","author":"Cheng","year":"2007","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.biopha.2023.115875_bib137","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3390\/ma11071167","article-title":"Antileishmanial activity of amphotericin b-loaded-PLGA nanoparticles: an overview","volume":"11","author":"Palma","year":"2018","journal-title":"Materials"},{"key":"10.1016\/j.biopha.2023.115875_bib138","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.msec.2015.10.083","article-title":"Development of PLGA-PEG encapsulated miltefosine based drug delivery system against visceral leishmaniasis","volume":"59","author":"Kumar","year":"2016","journal-title":"Mater. Sci. Eng. C. Mater. Biol. Appl."},{"issue":"10","key":"10.1016\/j.biopha.2023.115875_bib139","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3109\/10611860903115308","article-title":"Mannosylated nanoparticulate carriers of rifabutin for alveolar targeting","volume":"17","author":"Nimje","year":"2009","journal-title":"J. Drug Target"},{"issue":"12","key":"10.1016\/j.biopha.2023.115875_bib140","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1007\/s11095-009-9973-4","article-title":"Preparation, characterization and evaluation of targeting potential of amphotericin B-loaded engineered PLGA nanoparticles","volume":"26","author":"Nahar","year":"2009","journal-title":"Pharm. Res"},{"issue":"4","key":"10.1016\/j.biopha.2023.115875_bib141","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.nantod.2015.06.006","article-title":"Nanoparticle uptake: the phagocyte problem","volume":"10","author":"Gustafson","year":"2015","journal-title":"Nano Today"},{"issue":"1","key":"10.1016\/j.biopha.2023.115875_bib142","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2217\/nnm.15.188","article-title":"The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery","volume":"11","author":"Corbo","year":"2016","journal-title":"Nanomedicines"},{"issue":"6","key":"10.1016\/j.biopha.2023.115875_bib143","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1039\/D2LC00799A","article-title":"Nanoparticle protein corona: from structure and function to therapeutic targeting","volume":"23","author":"Bashiri","year":"2023","journal-title":"Lab Chip"},{"issue":"8","key":"10.1016\/j.biopha.2023.115875_bib144","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1021\/ja107583h","article-title":"Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles","volume":"133","author":"Monopoli","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biopha.2023.115875_bib145","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.567365","article-title":"Opsonins and dysopsonins of nanoparticles: facts, concepts, and methodological guidelines","volume":"11","author":"Papini","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2023.115875_bib146","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4638192","article-title":"The dual role of the liver in nanomedicine as an actor in the elimination of nanostructures or a therapeutic target","volume":"2020","author":"Baboci","year":"2020","journal-title":"J. Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2023.115875_bib147","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1189\/jlb.4VMLT0215-054R","article-title":"The liver sinusoidal endothelium reappears after being eclipsed by the Kupffer cell: a 20th century biological delusion corrected","volume":"98","author":"Anderson","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.biopha.2023.115875_bib148","doi-asserted-by":"crossref","first-page":"909","DOI":"10.2147\/IJN.S349426","article-title":"Advances in nanoliposomes for the diagnosis and treatment of liver cancer","volume":"17","author":"Li","year":"2022","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.biopha.2023.115875_bib149","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/polym13010005","article-title":"Effect of mixing ratio of oppositely charged block copolymers on polyion complex micelles for in vivo application","volume":"13","author":"Nakamura","year":"2020","journal-title":"Polymers"},{"issue":"26","key":"10.1016\/j.biopha.2023.115875_bib150","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb8133","article-title":"Transient stealth coating of liver sinusoidal wall by anchoring two-armed PEG for retargeting nanomedicines","volume":"6","author":"Dirisala","year":"2020","journal-title":"Sci. Adv."},{"issue":"10","key":"10.1016\/j.biopha.2023.115875_bib151","doi-asserted-by":"crossref","first-page":"10130","DOI":"10.1021\/acsnano.8b04947","article-title":"Dense and dynamic polyethylene glycol shells cloak nanoparticles from uptake by liver endothelial cells for long blood circulation","volume":"12","author":"Zhou","year":"2018","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.biopha.2023.115875_bib152","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nantod.2014.04.008","article-title":"Challenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospects","volume":"9","author":"Barua","year":"2014","journal-title":"Nano Today"},{"key":"10.1016\/j.biopha.2023.115875_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114238","article-title":"Why nanoparticles prefer liver macrophage cell uptake in vivo","volume":"185","author":"Ngo","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"20","key":"10.1016\/j.biopha.2023.115875_bib154","doi-asserted-by":"crossref","first-page":"11300","DOI":"10.3390\/ijms222011300","article-title":"Stimulus-responsive smart nanoparticles-based CRISPR-cas delivery for therapeutic genome editing","volume":"22","author":"Naeem","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2023.115875_bib155","doi-asserted-by":"crossref","first-page":"10636","DOI":"10.1021\/acsnano.8b06104","article-title":"Stimuli-responsive nano-architecture drug-delivery systems to solid tumormicromilieu: past, present, and future perspectives","volume":"12","author":"El-Sawy","year":"2018","journal-title":"ACS Nano"},{"issue":"32","key":"10.1016\/j.biopha.2023.115875_bib156","doi-asserted-by":"crossref","first-page":"29330","DOI":"10.1021\/acsami.9b10211","article-title":"Mitochondria-specific anticancer drug delivery based on reduction-activated polyprodrug for enhancing the therapeutic effect of breast cancer chemotherapy","volume":"11","author":"Wang","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"5","key":"10.1016\/j.biopha.2023.115875_bib157","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3390\/polym14050936","article-title":"pH-responsive nanocarriers in cancer therapy","volume":"14","author":"AlSawaftah","year":"2022","journal-title":"Polymers"},{"issue":"39","key":"10.1016\/j.biopha.2023.115875_bib158","doi-asserted-by":"crossref","first-page":"22375","DOI":"10.1021\/acs.jpcc.6b06759","article-title":"Dual-responsive mesoporous silica nanoparticles mediated codelivery of doxorubicin and Bcl-2 SiRNA for targeted treatment of breast cancer","volume":"120","author":"Zhou","year":"2016","journal-title":"J. Phys. Chem. C."},{"issue":"1","key":"10.1016\/j.biopha.2023.115875_bib159","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-41150-0","article-title":"Co-delivery of streptomycin and hydroxychloroquine by labeled solid lipid nanoparticles to treat brucellosis: an animal study","volume":"13","author":"Moez","year":"2023","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2023.115875_bib160","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ijantimicag.2017.08.009","article-title":"Effect of hydroxychloroquine on treatment and recurrence of acute brucellosis: a single-blind, randomized clinical trial","volume":"51","author":"Majzoobi","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.biopha.2023.115875_bib161","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.apsusc.2019.05.157","article-title":"Fabrication of pH-sensitive thin-film nanocomposite nanofiltration membranes with enhanced performance by incorporating amine-functionalized graphene oxide","volume":"487","author":"Shao","year":"2019","journal-title":"Appl. Surf. Sci."},{"issue":"8","key":"10.1016\/j.biopha.2023.115875_bib162","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.apsb.2021.03.033","article-title":"Influencing factors and strategies of enhancing nanoparticles into tumors in vivo","volume":"11","author":"Zhang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"6","key":"10.1016\/j.biopha.2023.115875_bib163","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/cplu.201600085","article-title":"pH-dependent cancer-directed photodynamic therapy by a water-soluble graphitic-phase carbon nitride-porphyrin nanoprobe","volume":"81","author":"Chan","year":"2016","journal-title":"Chempluschem"},{"key":"10.1016\/j.biopha.2023.115875_bib164","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.colsurfb.2018.11.006","article-title":"Synthesis and characterization of magnetic hybrid nanomaterials via RAFT polymerization: A pH sensitive drug delivery system","volume":"174","author":"Pourjavadi","year":"2019","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"6","key":"10.1016\/j.biopha.2023.115875_bib165","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.cclet.2020.03.001","article-title":"pH-Sensitive nanoscale materials as robust drug delivery systems for cancer therapy","volume":"31","author":"Shi","year":"2020","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.biopha.2023.115875_bib166","doi-asserted-by":"crossref","first-page":"49","DOI":"10.14356\/kona.2018011","article-title":"Direct permeation of nanoparticles across cell membrane: a review","volume":"35","author":"Nakamura","year":"2018","journal-title":"KONA Powder Part. J."},{"issue":"4","key":"10.1016\/j.biopha.2023.115875_bib167","first-page":"341","article-title":"Advances in technology and business potential of new drug delivery systems","volume":"6","author":"Momin","year":"2016","journal-title":"Drug Deliv. Transl. Res"},{"issue":"4","key":"10.1016\/j.biopha.2023.115875_bib168","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2016015798","article-title":"Overview on therapeutic applications of microparticulate drug delivery systems","volume":"33","author":"Bale","year":"2016","journal-title":"Crit. Rev. Ther. Drug Carr. Syst."},{"issue":"1","key":"10.1016\/j.biopha.2023.115875_bib169","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0378-5173(99)00448-2","article-title":"Gentamicin encapsulation in PLA\/PLGA microspheres in view of treating Brucella infections","volume":"196","author":"Prior","year":"2000","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2023.115875_bib170","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1093\/jac\/dki144","article-title":"Gentamicin-loaded microspheres for treatment of experimental Brucella abortus infection in mice","volume":"55","author":"Prior","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"issue":"24","key":"10.1016\/j.biopha.2023.115875_bib171","doi-asserted-by":"crossref","DOI":"10.1088\/0953-8984\/28\/24\/240401","article-title":"New developments in classical density functional theory","volume":"28","author":"Evans","year":"2016","journal-title":"J. Phys. Condens Matter"},{"issue":"18","key":"10.1016\/j.biopha.2023.115875_bib172","doi-asserted-by":"crossref","first-page":"14155","DOI":"10.3390\/ijms241814155","article-title":"Review of applications of density functional theory (DFT) quantum mechanical calculations to study the high-pressure polymorphs of organic crystalline materials","volume":"24","author":"Napi\u00f3rkowska","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.biopha.2023.115875_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2022.104088","article-title":"Experimental, DFT and theoretical corrosion study for 4-(((4-ethyl-5-(thiophen-2-yl)-4H-1,2,4-triazole-3-yl)thio)methyl)-7,8-dimethyl-2H-chromen-2-one","volume":"15","author":"Parlak","year":"2022","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.biopha.2023.115875_bib174","first-page":"315","article-title":"Molecular electrostatic potential surface, HOMO\u2013LUMO, and computational analysis of synthetic drug Rilpivirine","volume":"7","author":"Braga","year":"2016","journal-title":"Int J. Sci. Eng. Res"},{"issue":"28","key":"10.1016\/j.biopha.2023.115875_bib175","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.molstruc.2012.01.007","article-title":"Four novel ketocoumarin-based chromophores: synthesis, photoluminescent behaviors and theoretical studies","volume":"1012","author":"Li","year":"2012","journal-title":"J. Mol. Struct."},{"issue":"9","key":"10.1016\/j.biopha.2023.115875_bib176","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011590","article-title":"Better efficacy of triple antibiotics therapy for human brucellosis: A systematic review and meta-analysis","volume":"17","author":"Huang","year":"2023","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.biopha.2023.115875_bib177","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.733064","article-title":"Bacterial outer membrane vesicles as antibiotic delivery vehicles","volume":"12","author":"Collins","year":"2021","journal-title":"Front Immunol."},{"issue":"7","key":"10.1016\/j.biopha.2023.115875_bib178","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010635","article-title":"Antibiotic persistence of intracellular Brucella abortus","volume":"16","author":"Mode","year":"2022","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"9","key":"10.1016\/j.biopha.2023.115875_bib179","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.3390\/pharmaceutics13091340","article-title":"Nanoparticles to target and treat macrophages: the Ockham's Concept?","volume":"13","author":"Medrano-Bosch","year":"2021","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.biopha.2023.115875_bib180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0269963","article-title":"Brucella species-induced brucellosis: antimicrobial effects, potential resistance and toxicity of silver and gold nanosized particles","volume":"17","author":"Elbehiry","year":"2022","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.biopha.2023.115875_bib181","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.3390\/nano12111855","article-title":"Recent advances in antimicrobial nano-drug delivery systems","volume":"12","author":"Zong","year":"2022","journal-title":"Nanomater. (Basel)"},{"key":"10.1016\/j.biopha.2023.115875_bib182","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2147\/IJN.S283686","article-title":"Nanomedicine for the SARS-CoV-2: state-of-the-art and future prospects","volume":"16","author":"Varahachalam","year":"2021","journal-title":"Int J. Nanomed."},{"key":"10.1016\/j.biopha.2023.115875_bib183","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jconrel.2022.03.049","article-title":"Targeted nanomedicine in cisplatin-based cancer therapeutics","volume":"345","author":"Han","year":"2022","journal-title":"J. Control Release"},{"issue":"12","key":"10.1016\/j.biopha.2023.115875_bib184","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3390\/antibiotics10121473","article-title":"Nanotechnology as a novel approach in combating microbes providing an alternative to antibiotics","volume":"10","author":"Mubeen","year":"2021","journal-title":"Antibiotics"},{"issue":"3","key":"10.1016\/j.biopha.2023.115875_bib185","doi-asserted-by":"crossref","DOI":"10.1177\/1559325820936161","article-title":"Nanoparticle-based drug delivery system: a patient-friendly chemotherapy for oncology","volume":"18","author":"Yan","year":"2020","journal-title":"Dose Response"},{"issue":"8","key":"10.1016\/j.biopha.2023.115875_bib186","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3390\/nano9081167","article-title":"Spray-dried, nanoencapsulated, multi-drug anti-tuberculosis therapy aimed at once weekly administration for the duration of treatment","volume":"9","author":"Kalombo","year":"2019","journal-title":"Nanomaterials"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223016736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223016736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:25:02Z","timestamp":1777577102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223016736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":186,"alternative-id":["S0753332223016736"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115875","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nano and microparticle drug delivery systems for the treatment of Brucella infections","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115875","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115875"}}